{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:47:24Z","timestamp":1787647644048,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NCI","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1136\/ijgc-2021-002885","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T09:50:45Z","timestamp":1640857845000},"page":"159-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Ovarian cancer recurrence detection may not require in-person physical examination: an MSK team ovary study"],"prefix":"10.1016","volume":"32","author":[{"given":"Jacqueline","family":"Feinberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Carthew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaity","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nita","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis S","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Long Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginger","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Zivanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2021-002885_bb0010","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2021-002885_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2017.03.022","article-title":"An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of gynecologic oncology (SGO) recommendations","volume":"146","author":"Salani","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002885_bb0020","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/sj.bjc.6605963","article-title":"The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review","volume":"103","author":"Rettenmaier","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2021-002885_bb0025","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2010.01.014","article-title":"Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?","volume":"117","author":"Tanner","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002885_bb0030","year":"2021","journal-title":"Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed"},{"key":"10.1136\/ijgc-2021-002885_bb0035","year":"2021","journal-title":"Interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic"},{"key":"10.1136\/ijgc-2021-002885_bb0040","author":"(NCCN) NCCN","year":"2021","journal-title":"NCCN clinical practice Guidlines: ovarian cancer including fallopian tube cancer and primary peritoneal cancer version 2"},{"key":"10.1136\/ijgc-2021-002885_bb0045","article-title":"Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment","volume":"9","author":"Clarke","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ijgc-2021-002885_bb0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ygyno.2010.10.028","article-title":"Ovarian cancer patient surveillance after curative-intent initial treatment","volume":"120","author":"Harmandayan","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002885_bb0055","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ijgc-00009577-200601000-00061","article-title":"Routine follow-up after treatment for a gynecological cancer: a survey of practice","volume":"16","author":"Kew","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-002885_bb0060","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/djg036","article-title":"A randomized clinical trial of cisplatin\/paclitaxel versus carboplatin\/paclitaxel as first-line treatment of ovarian cancer","volume":"95","author":"du Bois","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2021-002885_bb0065","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","article-title":"Olaparib plus bevacizumab as first-line maintenance in ovarian cancer","volume":"381","author":"Ray-Coquard","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2021-002885_bb0070","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/IGC.0b013e3182070f17","article-title":"Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and Ca 125 agreed by the gynecological cancer intergroup (GCIG)","volume":"21","author":"Rustin","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-002885_bb0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0093-7754(03)00100-3","article-title":"The follow-up of ovarian cancer","volume":"30","author":"Vaidya","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1136\/ijgc-2021-002885_bb0080","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.7314\/APJCP.2013.14.12.7193","article-title":"Detection of recurrence in a surveillance program for epithelial ovarian cancer","volume":"14","author":"Suprasert","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1136\/ijgc-2021-002885_bb0085","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ygyno.2008.04.030","article-title":"The role of regular physical examination in the detection of ovarian cancer recurrence","volume":"110","author":"Chan","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002885_bb0090","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/IGC.0b013e3181a1cc02","article-title":"Are surveillance procedures of clinical benefit for patients treated for ovarian cancer?: a retrospective Italian multicentric study","volume":"19","author":"Gadducci","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-002885_bb0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ygyno.2006.02.005","article-title":"Follow-up of ovarian and primary peritoneal carcinoma: the value of physical examination in patients with pretreatment elevated CA125 levels","volume":"103","author":"Menczer","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002885_bb0100","article-title":"The role of asymptomatic screening in the detection of recurrent ovarian cancer","volume":"33","author":"Richardson","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"10.1136\/ijgc-2021-002885_bb0105","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ygyno.2005.08.057","article-title":"The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian cancer","volume":"100","author":"Parker","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002885_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000292352","article-title":"CA-125 monitoring in ovarian cancer: patient survey responses to the results of the MRC\/EORTC CA-125 surveillance trial","volume":"78","author":"Markman","year":"2010","journal-title":"Oncology"},{"key":"10.1136\/ijgc-2021-002885_bb0115","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/IGC.0b013e31827f37b0","article-title":"Life after gynecologic cancer--a review of patients quality of life, needs, and preferences in regard to follow-up","volume":"23","author":"Dahl","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-002885_bb0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ygyno.2021.04.037","article-title":"Virtual visits among gynecologic oncology patients during the COVID-19 pandemic are accessible across the social vulnerability spectrum","volume":"162","author":"McAlarnen","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002885_bb0125","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/ijgc-2020-001942","article-title":"Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)","volume":"31","author":"Mancebo","year":"2021","journal-title":"Int J Gynecol Cancer"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24005747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24005747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2021-002885","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:39:36Z","timestamp":1753223976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24005747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1048891X24005747"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2021-002885","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian cancer recurrence detection may not require in-person physical examination: an MSK team ovary study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2021-002885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}